SCHEMBL25533950

SCHEMBL25533950

CC(C)C(C)c1ncn2ccccc12

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
HPGD P15428 1/20 0.34
HSD17B10 Q99714 1/20 0.34
PDE5A O76074 3/20 0.33
MIF P14174 2/20 0.33
PDE4B Q07343 2/20 0.33
PDE3A Q14432 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
TSHR P16473 1/20 0.33
PDE4A P27815 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
CYP2C19 P33261 1/20 0.33
BLM P54132 1/20 0.33
PDE4C Q08493 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17248114 0.89 PDE4B (0.41) MEN1KMT2AHPGDHSD17B10PDE5A
SCHEMBL23587102 0.81 TSHR (0.34) MEN1KMT2AHPGDHSD17B10PDE5A
SCHEMBL25584288 0.79 POLB (0.34) MIFALDH1A1TSHRAPLNR
SCHEMBL26123113 0.76 DRD4 (0.30)
SCHEMBL23382287 0.74 SLC6A2 (0.33) APLNRSLC6A2
SCHEMBL9934394 0.72 PTPN2 (0.37) HPGDHSD17B10ALDH1A1CYP1A2CYP2D6
SCHEMBL11166846 0.71 DRD4 (0.38) MEN1KMT2AHPGDHSD17B10MIF
Hydrochloric Acid SCHEMBL10361149 0.71 PTPN2 (0.36) HPGDHSD17B10ALDH1A1CYP1A2CYP2D6
SCHEMBL19866687 0.69 ALOX15 (0.33) HPGDALDH1A1ALOX15
SCHEMBL25246743 0.69 SLC6A2 (0.39) KMT2AADORA2AADORA1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230145249-A1 Monoacylglycerol Lipase Modulators JANSSEN PHARMACEUTICA NV (BE) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230145249-A1 Monoacylglycerol Lipase Modulators MGLL, LPL, PNLIP MEN1 4128/4885KMT2A 1069/4885HPGD 1749/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.